MidCap Financial Investment Corporation
APDOL
OTC PK
| Weiss Ratings | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 2.91B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 1.30 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 93.90M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 141.29% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 515 3200 | |||
| Address | Nine West 57th Street New York, NY 10019 | |||
| Website | www.midcapfinancialic.com | |||
| Country | United States | |||
| Year Founded | 2004 | |||
| Profitability | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 82.59% | |||
| Profit Margin | 32.74% | |||
| Management Effectiveness | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.47% | |||
| Return on Equity | 8.20% | |||
| Income Statement | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | 301.78M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 301.78M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | 249.26M | |||
| Net Income (TTM) | 98.82M | |||
| Net Income Avl. to Common (TTM) | 98.82M | |||
| Total Revenue Growth (Q YOY) | 14.18% | |||
| Earnings Growth (Q YOY) | -27.67% | |||
| EPS Diluted (TTM) | 1.30 | |||
| EPS Diluted Growth (Q YOY) | -49.74% | |||
| Balance Sheet | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 75.79M | |||
| Cash Per Share (Q) | $0.81 | |||
| Total Current Assets (Q) | 152.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.40B | |||
| Current Ratio (Q) | 0.404 | |||
| Book Value Per Share (Q) | $14.98 | |||
| Total Assets (Q) | 3.19B | |||
| Total Current Liabilities (Q) | 378.65M | |||
| Total Debt (Q) | 1.75B | |||
| Total Liabilities (Q) | 1.79B | |||
| Total Common Equity (Q) | 1.40B | |||
| Cash Flow | APDOL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -36.76M | |||
| Net Change in Cash (TTM) | -46.34M | |||
| Levered Free Cash Flow (TTM) | 40.40M | |||
| Cash from Operations (TTM) | -9.53M | |||
